rethinkTHC Search
Menu
Study breakdown

Medical Marijuana Patients Report Sustained Relief From GI Symptoms Over One Year

ObservationalPreliminary evidence
The takeaway

Patients with chronic gastrointestinal symptoms who used medical marijuana reported significant decreases in symptom severity at every time point over 12 months.

Patients with chronic GI conditions exploring medical cannabis; gastroenterologists considering cannabis as a therapeutic option.

Significant GI symptom improvement at all 4 time points over 12 months (p < 0.05)

What the researchers found

At each survey (baseline, 30 days, 6 months, 12 months), participants reported significantly lower GI symptom severity when using medical marijuana versus when not using it (p < 0.05 at every time point).

Why it matters

Chronic GI conditions like IBS and Crohn's disease are notoriously difficult to manage. This 12-month follow-up provides some of the first evidence that medical marijuana's benefits for GI symptoms persist over time rather than diminishing with continued use.

The numbers in context

Significant symptom severity decrease at all four time points (p < 0.05). Most common side effects: increased appetite (12-21.4%), fatigue (6-16.7%), anxiety (4-11.9%), cough (4-11.9%), headache (6-7.9%), dry mouth (4-7.1%).

How the study worked

Longitudinal observational study following medical marijuana patients who completed surveys at baseline, 30 days, 6 months, and 12 months. GI symptom severity was self-rated on a 1 (mild) to 3 (severe) scale. Side effects were also tracked.

What this study cannot tell us

Self-reported outcomes without a placebo control group make it impossible to separate the pharmacological effects of marijuana from placebo effects or natural symptom fluctuation. No standardized GI diagnosis was required for enrollment. The simple 3-point severity scale limits granularity.

How to read the evidence

Preliminary: longitudinal self-reported data over 12 months shows consistency, but lacks placebo control, objective measures, and specific diagnoses.

When this study was published

2024 study.

The bigger picture

The endocannabinoid system is densely distributed throughout the gut and plays a role in motility, inflammation, and pain signaling. These patient-reported improvements align with preclinical evidence that cannabinoids modulate gastrointestinal function through multiple pathways.

Questions still open

  • Which specific GI conditions respond best to medical marijuana? Do different cannabis formulations (high-THC vs high-CBD vs balanced) produce different GI outcomes?

Common questions

Did the relief wear off over time?
No. Participants reported significant symptom improvement at every time point measured -- 30 days, 6 months, and 12 months -- suggesting the benefits persisted rather than diminishing.
What were the most common side effects?
Increased appetite (up to 21%), fatigue (up to 17%), anxiety (up to 12%), and cough (up to 12%) were the most frequently reported side effects over the study period.

Read the original research

Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year.

Medical cannabis and cannabinoids, 7(1), 80-85

Citation

Wallingford, Matthew P; Kelly, Erin L; Herens, Allison; Hanna, Daniel; Hajjar, Emily; Worster, Brooke. (2024). Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year.. Medical cannabis and cannabinoids, 7(1), 80-85. https://doi.org/10.1159/000538694

Explore the wider topic